These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11255951)

  • 1. [Prevention of breast cancer].
    Lipnitskiĭ EM; Komissarov AB; Samodurova TE; Topchiĭ SN
    Vestn Ross Akad Med Nauk; 2001; (1):40-4. PubMed ID: 11255951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer of the breast after prophylactic subcutaneous mastectomy.
    Eldar S; Meguid MM; Beatty JD
    Am J Surg; 1984 Nov; 148(5):692-3. PubMed ID: 6496863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retrospective studies on the relation between fibrocystic disease and cancer of the breast with therapeutic conclusions].
    Georgescu T; Naftali Z; Simu G; Nistor V; Crăciu C; Ilniczky P; Boţianu A; Răibuleţ M
    Chirurgia (Bucur); 1992; 41(1):10-8. PubMed ID: 1361381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperplastic lesions of the high risk breast. Definitions, diagnostic and therapeutic problems].
    Scali P; Contesso G
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(2):155-62. PubMed ID: 1583292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrocystic breast disease--breast cancer sequence].
    Habor V; Habor A; Copotoiu C; Panţîru A
    Chirurgia (Bucur); 2010; 105(2):191-4. PubMed ID: 20540231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of prophylactic mastectomy.
    Ghosh K; Hartmann LC
    Oncology (Williston Park); 2002 Oct; 16(10):1319-25; discussion 1325, 1329-30, 1332. PubMed ID: 12435203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic bilateral mastectomy and contralateral prophylactic mastectomy.
    Chagpar AB
    Surg Oncol Clin N Am; 2014 Jul; 23(3):423-30. PubMed ID: 24882342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Does a sector resection of the breast cure nodal mastopathy?].
    Li LA; Martyniuk VV
    Vestn Khir Im I I Grek; 1998; 157(6):77-9. PubMed ID: 10672670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
    Hartmann LC; Schaid DJ; Woods JE; Crotty TP; Myers JL; Arnold PG; Petty PM; Sellers TA; Johnson JL; McDonnell SK; Frost MH; Jenkins RB
    N Engl J Med; 1999 Jan; 340(2):77-84. PubMed ID: 9887158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices.
    Geiger AM; Yu O; Herrinton LJ; Barlow WE; Harris EL; Rolnick S; Barton MB; Elmore JG; Fletcher SW
    Arch Intern Med; 2005 Mar; 165(5):516-20. PubMed ID: 15767526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathomorphology and indications in plastic surgery of the breast].
    Bässler R
    Z Plast Chir; 1979 Jul; 3(2):65-87. PubMed ID: 384701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of the surgical treatment of nodular forms of dyshormonal hyperplasia of the breast].
    Batalina LD
    Khirurgiia (Mosk); 1990 Apr; (4):28-30. PubMed ID: 2374350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressive therapy after surgical treatment of thyroid gland cancer in patients with mastopathy.
    Makaridze T; Mardaleishvili K
    Georgian Med News; 2007; (148-149):17-20. PubMed ID: 17921536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Are there still indications for subcutaneous mastectomy?].
    Olbrisch RR
    Chirurg; 1981 Jul; 52(7):467-71. PubMed ID: 7196311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pre-invasive tumors and precancerous conditions of the breast: subcutaneous mastectomy and reconstruction-plasty. Indications and results].
    Bohmert H
    Chirurg; 1984 Mar; 55(3):152-61. PubMed ID: 6325101
    [No Abstract]   [Full Text] [Related]  

  • 16. [The relationship between benign breast proliferation (fibrocystic mastopathy) and the appearance of breast carcinoma].
    Alexa O; Stolnicu S; Horváth E; Jung J
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(4):101-9. PubMed ID: 12089936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
    Rebbeck TR; Friebel T; Lynch HT; Neuhausen SL; van 't Veer L; Garber JE; Evans GR; Narod SA; Isaacs C; Matloff E; Daly MB; Olopade OI; Weber BL
    J Clin Oncol; 2004 Mar; 22(6):1055-62. PubMed ID: 14981104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic mastectomy for precancerous and high-risk lesions of the breast.
    Ariyan S
    Can J Surg; 1985 May; 28(3):262-4, 266. PubMed ID: 3995424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Subcutaneous mastectomy].
    Efting Dijkstra JD
    TVZ; 1988 Jan; 42(2):55-9. PubMed ID: 3127937
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cancer of the breast at a remote time after segmental resection].
    Batalina LD; Taktamysh AN
    Vopr Onkol; 1989; 35(7):864-6. PubMed ID: 2773406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.